NCT03286361View on ClinicalTrials.gov

Clinical Trial Investigating the BeGraft Peripheral Plus Stent Graft System for Iliac Lesion Treatment

NAActive, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 29, 2017

Primary Completion Date

April 24, 2023

Study Completion Date

April 30, 2025

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

BeGraft Peripheral Plus Stent Graft System

Patients will be treated with the BeGraft Peripheral Plus Stent Graft System

Trial Locations (9)

2820

Imelda Hospital, Bonheiden

9200

A.Z. Sint-Blasius, Dendermonde

9300

O.L.V. Hospital, Aalst

44093

CHU de Nantes, Nantes

Unknown

ZNA, Antwerp

ZOL, Genk

az Groeninge, Kortrijk

RZ Heilig Hart, Tienen

AZ Jan Portaels, Vilvoorde

Sponsors

Lead Sponsor

ID3 Medical
All Listed Sponsors
lead

ID3 Medical

OTHER

NCT03286361 - Clinical Trial Investigating the BeGraft Peripheral Plus Stent Graft System for Iliac Lesion Treatment | Biotech Hunter | Biotech Hunter